Coordinate activation of Shh and PI3K signaling in PTEN-deficient glioblastoma: new therapeutic opportunities
Filbin, Mariella Gruber, Dabral, Sukriti K, Pazyra-Murphy, Maria F, Ramkissoon, Shakti, Kung, Andrew L, Pak, Ekaterina, Chung, Jarom, Theisen, Matthew A, Sun, Yanping, Franchetti, Yoko, Sun, Yu, Shulman, David S, Redjal, Navid, Tabak, Barbara, Beroukhim, Rameen, Wang, Qi, Zhao, Jean, Dorsch, Marion, Buonamici, Silvia, Ligon, Keith L, Kelleher, Joseph F, Segal, Rosalind A
Published in Nature medicine (01.11.2013)
Published in Nature medicine (01.11.2013)
Get full text
Journal Article
LGG-44. A PHASE I DOSE ESCALATION TRIAL OF THE MEK1/2 INHIBITOR MEK162 (BINIMETINIB) IN CHILDREN WITH LOW-GRADE GLIOMAS AND OTHER RAS/RAF PATHWAY-ACTIVATED TUMORS
Robison, Nathan, Pauly, Jasmine, Malvar, Jemily, Gruber-Filbin, Mariella, de Mola, Rebecca Loret, Dorris, Kathleen, Bendel, Anne, Bowers, Daniel, Bornhorst, Miriam, Gauvain, Karen, Leary, Sarah, Diaz, Patricia, Tan, Yi Juin, Margol, Ashley, Dhall, Girish, Rosser, Tena, Bandopadhayay, Pratiti, Davidson, Tom, Ullrich, Nicole, Borchert, Mark, Nelson, Marvin, Sinai, Claire, Ligon, Keith, Sposto, Richard, Kieran, Mark
Published in Neuro-oncology (Charlottesville, Va.) (22.06.2018)
Published in Neuro-oncology (Charlottesville, Va.) (22.06.2018)
Get full text
Journal Article